Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines.
10.5653/cerm.2017.44.4.171
- Author:
Jayeon KIM
1
;
Seul Ki KIM
;
Kyung Joo HWANG
;
Seok Hyun KIM
Author Information
1. Department of Obstetrics and Gynecology, Cha Fertility Center at Seoul Station, CHA University, Seoul, Korea.
- Publication Type:Review
- Keywords:
Clinical practice;
Fertility preservation;
Neoplasms;
Patient care
- MeSH:
Endocrinology;
Fertility Preservation*;
Fertility*;
Geography;
Humans;
Laboratory Personnel;
Mental Health;
Patient Care;
Referral and Consultation;
Specialization
- From:Clinical and Experimental Reproductive Medicine
2017;44(4):171-174
- CountryRepublic of Korea
- Language:English
-
Abstract:
While many fertility preservation (FP) options now exist for reproductive-aged cancer patients, access to these services continues to be limited. A comprehensive FP program should be organized to serve oncofertility patients effectively. Also, much effort is needed from various individuals—patients, specialists from various fields, and consultants—to facilitate FP in a timely manner. Various challenges still exist in improving access to FP programs. To improve access to FP treatment, it is important to educate oncologists and patients via electronic tools and to actively navigate patients through the system. Reproductive endocrinology practices that receive oncofertility referrals must be equipped to provide a full range of options on short notice. A multidisciplinary team approach is required, involving physicians, nurses, mental health professionals, office staff, and laboratory personnel. The bottom line of FP patient care is to understand the true nature of each patient's specific situation and to develop a patient flow system that will help build a successful FP program. Expanding the patient flow system to all comprehensive cancer centers will ensure that all patients are provided with adequate information regarding their fertility, regardless of geography.
